F2 MG Ltd - Director, 10%+ Owner at Kalaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
KLRS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by F2 MG Ltd since 30 Jan 2025

Holdings reported by F2 MG Ltd for Kalaris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4,193,874 $2,813,251 $0.6708 28 Jul 2022 By F2 Capital I 2020 LLC
Common Stock 2,059,884 $1,381,770 $0.6708 28 Jul 2022 Direct
Common Stock 2,038,583 $1,367,481 $0.6708 28 Jul 2022 By F2 MC, LLC
Common Stock 867,678 $582,038 $0.6708 28 Jul 2022 By F2 Bioscience AV 2022 LLC
Common Stock 668,072 $448,143 $0.6708 28 Jul 2022 By F2-TPO Investments, LLC

There are no transactions reported by F2 MG Ltd for Kalaris Therapeutics, Inc.